Therefore, it is possible to suggest that zonulin might play a role not only as a marker of impaired intestinal permeability, but also as a possible indicator of early metabolic disorders in children and adolescents with overweight and obesity, helping to identify patients at increased risk of developing obesity-related complications due to IR. This evidence concerns the gene HP and Other metabolic disease.